VOLITIONRX LTD — Director's Dealing 2022

Jun 17, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2022-05-01-05:00

Reporting Person: Butera Salvatore Thomas (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-01-05:00	Common Stock	F	15000	$2.79	Disposed	145000	Direct
2022-06-16-05:00	Common Stock	P	10000	$2.05	Acquired	155000	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	7000	Direct

Footnotes

F1: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 50,000 restricted stock units. No shares were sold by the reporting person or VolitionRx in such transaction.

F2: These shares of common stock are jointly owned by the reporting person and his spouse.